These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38740381)
1. Prediction of Prognostic Features Based on Neutrophil-Related Genes for Lung Squamous Cell Carcinoma Reveals Immune Landscape and Drug Candidates. Sili D; Nan Z Rev Invest Clin; 2024; 76(2):116-131. PubMed ID: 38740381 [TBL] [Abstract][Full Text] [Related]
2. Significance of Lin H; Wang J; Shi Q; Wu M PeerJ; 2024; 12():e17338. PubMed ID: 38708353 [TBL] [Abstract][Full Text] [Related]
3. Characterization of prognostic signature related with twelve types of programmed cell death in lung squamous cell carcinoma. Li S; Ding B; Weng D J Cardiothorac Surg; 2024 Oct; 19(1):569. PubMed ID: 39354528 [TBL] [Abstract][Full Text] [Related]
4. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma. Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987 [TBL] [Abstract][Full Text] [Related]
5. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis. Fan T; Lu Z; Liu Y; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J Front Immunol; 2021; 12():665407. PubMed ID: 34177903 [TBL] [Abstract][Full Text] [Related]
6. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677 [TBL] [Abstract][Full Text] [Related]
7. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma. Xu F; Zhang H; Chen J; Lin L; Chen Y Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430 [TBL] [Abstract][Full Text] [Related]
8. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma. Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma. Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696 [No Abstract] [Full Text] [Related]
10. A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma. Qin R; Cao L; Ye C; Wang J; Sun Z BMC Med Genomics; 2021 Feb; 14(1):49. PubMed ID: 33588862 [TBL] [Abstract][Full Text] [Related]
11. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients. Wang K; Li Y; Wang J; Chen R; Li J Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782 [TBL] [Abstract][Full Text] [Related]
12. Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma. Lai X; Fu G; Du H; Xie Z; Lin S; Li Q; Lin K Medicine (Baltimore); 2023 Sep; 102(38):e35005. PubMed ID: 37746966 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Cell Death Index for Lung Adenocarcinoma: A Comprehensive Transcriptome-Based Analysis of Twelve Programmed Cell Death Pattern Genes. Chen F; Ma J; Hu S; Wu C; Chen S; Lin J Front Biosci (Landmark Ed); 2024 Apr; 29(4):135. PubMed ID: 38682187 [TBL] [Abstract][Full Text] [Related]
14. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma. Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909 [TBL] [Abstract][Full Text] [Related]
15. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma. Yang Q; Gong H; Liu J; Ye M; Zou W; Li H Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696 [TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinoma. Shi X; Dong A; Jia X; Zheng G; Wang N; Wang Y; Yang C; Lu J; Yang Y Front Immunol; 2022; 13():992990. PubMed ID: 36311764 [TBL] [Abstract][Full Text] [Related]
17. Neutrophil estimation and prognosis analysis based on existing lung squamous cell carcinoma datasets: the development and validation of a prognosis prediction model. Wang Y; Li D; Li Q; Basnet A; Efird JT; Seki N Transl Lung Cancer Res; 2024 Aug; 13(8):2023-2037. PubMed ID: 39263021 [TBL] [Abstract][Full Text] [Related]
18. Construction and Validation of a Protein Prognostic Model for Lung Squamous Cell Carcinoma. Fang X; Liu X; Weng C; Wu Y; Li B; Mao H; Guan M; Lu L; Liu G Int J Med Sci; 2020; 17(17):2718-2727. PubMed ID: 33162799 [TBL] [Abstract][Full Text] [Related]
19. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index. Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C Front Immunol; 2023; 14():1236444. PubMed ID: 37841237 [TBL] [Abstract][Full Text] [Related]
20. Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma. Mao G; Yang D; Liu B; Zhang Y; Ma S; Dai S; Wang G; Tang W; Lu H; Cai S; Zhu J; Yang H Respir Res; 2023 Jul; 24(1):176. PubMed ID: 37415224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]